An overview of monkey pox disease as an important disease in the world

Document Type : Review Article

Authors

1 Razi Vaccine & Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), P.O. Box 31975-148, Karaj, Iran

2 Poultry Vaccine Production Department, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension, Karaj, Iran

10.32592/ARI.2024.79.6.1121

Abstract

Monkey pox is a viral disease that has received much attention today due to the spread of re-emerging and emerging diseases, especially epidemic diseases.
Mpox was first identified as a distinct illness in 1958 among laboratory monkeys in Copenhagen, Denmark. The first case of monkeypox infection in humans was reported in 1970 in the Democratic Republic of the Congo in a boy aged 9 months who was the only member of his family without a smallpox vaccination. Monkeypox virus is a zoonotic virus belonging to the family Poxviridae, subfamily chordopoxvirinae, and genus orthopoxvirus.
The monkey pox is transmitted by touching and direct contact with a surface or a person infected with the virus. Also human-to-human transmission can occur through body fluids of the infected person.
In this review article, all aspects of this disease are discussed, so that after an introduction about the disease, history of the disease, virology, clinical features of the disease and its complications, clinical differential diagnosis with similar diseases, epidemiology of the disease, the prevalance of the disease, animal hosts range, virus transmission, disease diagnosis, prevention and treatment, and finally the risks of the disease in the future (future threats) are discussed.
Based on this, all the aspects of the disease have been reviewed in this article, which can be very beneficial for researchers and especially for the policymakers in the field of health and public health, because by knowing this disease and because of the health importance of the disease and the fact that the disease is a zoonosis disease between humans and animals can be affected to prevent this disease.

Keywords

Main Subjects

References

  1. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe J-J, Marks M, et al. Monkeypox. The Lancet. 2023;401(10370):60-74.
  2. Letafati A, Sakhavarz T. Monkeypox virus: A review. Microbial pathogenesis. 2023;176:106027.
  3. Parker S, Buller RM. A Review of Experimental and Natural Infections of Animals with Monkeypox Virus Between 1958 and 2012. Future Virology. 2013;8(2):129-57.
  4. Adepoju P. Mpox declared a public health emergency. The Lancet. 2024;404(10454):e1-e2.
  5. Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, et al. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. Journal of Infection and Public Health. 2023;16(4):531-41.
  6. Cho CT, Wenner HA. Monkeypox virus. Bacteriological reviews. 1973;37(1):1-18.
  7. Lim CK, Roberts J, Moso M, Liew KC, Taouk ML, Williams E, et al. Mpox diagnostics: Review of current and emerging technologies. 2023;95(1):e28429.
  8. Okwor T, Mbala PK, Evans DH, Kindrachuk J. A contemporary review of clade-specific virological differences in monkeypox viruses. Clinical Microbiology and Infection. 2023;29(12):1502-7.
  9. Yu X, Shi H, Cheng G. Mpox Virus: Its Molecular Evolution and Potential Impact on Viral Epidemiology. 2023;15(4):995.
  10. Li Y, Lv S, Zeng Y, Chen Z, Xia F, Zhang H, et al. Evaluation of Stability, Inactivation, and Disinfection Effectiveness of Mpox Virus. 2024;16(1):104.
  11. Lansiaux E, Jain N, Laivacuma S, Reinis A. The virology of human monkeypox virus (hMPXV): A brief overview. Virus Res. 2022;322:198932.
  12. Basu K, Krugliak M, Arkin IT. Viroporins of Mpox Virus. 2023;24(18):13828.
  13. Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. The New England journal of medicine. 2022;387(19):1783-93.
  14. Ogoina D, Dalhat MM, Denue BA, Okowa M, Chika-Igwenyi NM, Yusuff HA, et al. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study. 2023;23(12):1418-28.
  15. Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. 2023;120(8):e2220415120.
  16. Branda F, Romano C, Ciccozzi M, Giovanetti M, Scarpa F, Ciccozzi A, et al. Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications. 2024;13(8):2234.
  17. Ogoina D, Damon I, Nakoune E. Clinical review of human mpox. Clinical Microbiology and Infection. 2023;29(12):1493-501.
  18. Adetifa I, Muyembe J-J, Bausch DG, Heymann DL. Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world. The Lancet. 2023;401(10390):1822-4.
  19. Mortier C, Tissot-Dupont H, Cardona F, Bruel C, Lahouel S, Lasri H, et al. How to distinguish mpox from its mimickers: An observational retrospective cohort study. 2023;95(10):e29147.
  20. McCollum AM, Damon IKJCid. Human monkeypox. 2014;58(2):260-7.
  21. Christodoulidou MM, Mabbott NA. Efficacy of smallpox vaccines against Mpox infections in humans. Immunotherapy advances. 2023;3(1):ltad020.
  22. León-Figueroa DA, Barboza JJ, Garcia-Vasquez EA, Bonilla-Aldana DK, Diaz-Torres M, Saldaña-Cumpa HM, et al. Epidemiological situation of monkeypox transmission by possible sexual contact: a systematic review. 2022;7(10):267.
  23. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.
  24. YAO Kai-Hu DQ-Q, HU Ya-Hong. Diagnosis and treatment of human monkeypox. 2022;24(9):960-6.
  25. Caldas JP, Valdoleiros SR, Rebelo S, Tavares M. Monkeypox after Occupational Needlestick Injury from Pustule. Emerg Infect Dis. 2022;28(12):2516-9.
  26. McFarland SE, Marcus U, Hemmers L, Miura F, Iñigo Martínez J, Martínez FM, et al. Estimated incubation period distributions of mpox using cases from two international European festivals and outbreaks in a club in Berlin, May to June 2022. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2023;28(27).
  27. Estévez S, Vara M, Gamo M, Manzano S, Troya J, Botezat E, et al. Epidemiological and Clinical Characteristics of Patients Admitted to a Secondary Hospital with Suspected MPOX Virus Infection: Is HIV Playing a Role? Journal of clinical medicine. 2023;12(12).
  28. McCollum AMJMM, report mw. Epidemiology of human mpox—worldwide, 2018–2021. 2023;72.
  29. Blackburn DJMM, Report MW. Epidemiologic and clinical features of mpox in transgender and gender-diverse adults—United States, May–November 2022. 2022;71.
  30. Ferdous J, Barek MA, Hossen MS, Bhowmik KK, Islam MS. A review on monkeypox virus outbreak: New challenge for world. Health science reports. 2023;6(1):e1007.
  31. Shoaib HMJFiPH. Monkeypox as a potential emerging pandemic: a discussion on future risks and preparedness in Saudi Arabia. 2023;11:1254545.
  32. Siddiqui A, Essar MY, Rija A, Head MG, Nemat AJIJoS. Improving health system access and preparedness in Afghanistan to minimize potential impact of monkeypox: a call for action. 2023;109(2):156-7.
  33. Coşkun E, Soyak F, Öztürk-Deniz SS, Kutlu M, Sayın-Kutlu SJID, Microbiology C. Four Human Mpox Cases from Turkey. 2023;5(1):53.
  34. Ahmed SK, Abdulqadir SO, Omar RM, Abdullah AJ, Rahman HA, Hussein SH, et al. Knowledge, Attitude and Worry in the Kurdistan Region of Iraq during the Mpox (Monkeypox) Outbreak in 2022: An Online Cross-Sectional Study. Vaccines (Basel). 2023;11(3).
  35. Grothe JH, Cornely OA, Salmanton-García JJEIyMC. Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey. 2023;41(5):309.
  36. Dumonteil E, Herrera C, Sabino-Santos G. Monkeypox Virus Evolution before 2022 Outbreak. Emerg Infect Dis. 2023;29(2):451-3.
  37. Faherty EAJMM, Report MW. Notes from the field: emergence of an mpox cluster primarily affecting persons previously vaccinated against mpox—Chicago, Illinois, March 18–June 12, 2023. 2023;72.
  38. Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, et al. Outbreaks of Disease Suspected of Being Due to Human Monkeypox Virus Infection in the Democratic Republic of Congo in 2001. Journal of Clinical Microbiology. 2002;40(8):2919-21.
  39. Srivastava S, Kumar S, Jain S, Mohanty A, Thapa N, Poudel P, et al. The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review. Vaccines (Basel). 2023;11(6).
  40. Gaeta F, De Caro F, Franci G, Pagliano P, Vajro P, Mandato CJC. Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population. 2022;9(12):1832.
  41. Seang S, Burrel S, Todesco E, Leducq V, Monsel G, Le Pluart D, et al. Evidence of human-to-dog transmission of monkeypox virus. Lancet. 2022;400(10353):658-9.
  42. Besombes C, Mbrenga F, Malaka C, Gonofio E, Schaeffer L, Konamna X, et al. Investigation of a mpox outbreak in Central African Republic, 2021-2022. 2023;16:100523.
  43. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022. 2022;387(8):679-91.
  44. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. The Lancet Infectious Diseases. 2022;22(8):1153-62.
  45. Iizuka I, Saijo M, Shiota T, Ami Y, Suzaki Y, Nagata N, et al. Loop-mediated isothermal amplification-based diagnostic assay for monkeypox virus infections. 2009;81(6):1102-8.
  46. Davi SD, Kissenkötter J, Faye M, Böhlken-Fascher S, Stahl-Hennig C, Faye O, et al. Recombinase polymerase amplification assay for rapid detection of Monkeypox virus. Diagnostic Microbiology and Infectious Disease. 2019;95(1):41-5.
  47. Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virologica Sinica. 2022;37(4):477-82.
  48. Cho CT, Wenner HAJPotSfEB, Medicine. In vitro growth characteristics of monkeypox virus. 1972;139(3):916-20.
  49. Esposito JJ, Obijeski JF, Nakano JH. Serological relatedness of monkeypox, variola, and vaccinia viruses. 1977;1(1):35-47.
  50. Rana J, Patel SK, Agrawal A, Channabasappa NK, Niranjan AK, Chandra Das B, et al. Mpox vaccination in global perspective: priorities and challenges. Annals of Medicine and Surgery. 2023;85(5).
  51. Malik S, Ahmad T, Ahsan O, Muhammad K, Waheed Y. Recent Developments in Mpox Prevention and Treatment Options. 2023;11(3):500.
  52. Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nature Medicine. 2023;29(3):748-52.
  53. Berry MT, Khan SR, Schlub TE, Notaras A, Kunasekaran M, Grulich AE, et al. Predicting vaccine effectiveness for mpox. Nature Communications. 2024;15(1):3856.
  54. Group CID, Fox T, Gould S, Princy N, Rowland T, Lutje V, et al. Therapeutics for treating mpox in humans. 1996;2023(3).
  55. Siegrist EA, Sassine JJCid. Antivirals with activity against mpox: a clinically oriented review. 2023;76(1):155-64.
  56. Kumar N, Acharya A, Gendelman HE, Byrareddy SNJJoa. The 2022 outbreak and the pathobiology of the monkeypox virus. 2022;131:102855.
  57. Turner M, Mandia J, Keltner C, Haynes R, Faestel P, Mease LJEID. Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak. 2022;28(11):2336.
  58. Kozlov M. Can a Smallpox Drug Treat Monkeypox? What Scientists Know. NATURE PORTFOLIO HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY; 2022.
  59. Beer EM, Rao VBJPntd. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. 2019;13(10):e0007791.
  60. Falendysz EA, Lopera JG, Lorenzsonn F, Salzer JS, Hutson CL, Doty J, et al. Further assessment of monkeypox virus infection in Gambian pouched rats (Cricetomys gambianus) using in vivo bioluminescent imaging. 2015;9(10):e0004130.
  61. Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Frontiers in public health. 2018;6:241.
  62. Nguyen P-Y, Ajisegiri WS, Costantino V, Chughtai AA, MacIntyre CRJEID. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017–2020. 2021;27(4):1007.
Archives of Razi Institute
Volume 79, Issue 6
November and December 2024
Pages 1121-1133

Files

Share

How to cite

Statistics